erythromycin

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: erythromycin
Generic name: ERYTHROMYCIN
Manufacturer: Asclemed USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: 6186510d-62ca-4083-9895-8d028d71b510
SPL ID: 0523a539-bb30-676e-e063-6394a90af39b
Version: 1
Effective date: 2023-09-12
Source export date: 2026-09-28
Source partition: 3
Source file: https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/fd09911bd1bc81f7f2faeb048e63855fe224e494376ae919a0035190e315c050/drug-label-0003-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:17:52

Harmonized routes table
Harmonized routes
OPHTHALMIC

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application applno	ANDA	062447	derived:openfda.application_number
application number		ANDA062447	openfda.application_number
brand name		erythromycin	openfda.brand_name
generic name		ERYTHROMYCIN	openfda.generic_name
manufacturer name		Asclemed USA, Inc.	openfda.manufacturer_name
ndc	package	76420-612-03	openfda.package_ndc
ndc	product	76420-612	openfda.product_ndc
ndc11	package	76420061203	derived:openfda.package_ndc
rxcui		310149	openfda.rxcui
spl id		0523a539-bb30-676e-e063-6394a90af39b	id
spl set id		6186510d-62ca-4083-9895-8d028d71b510	set_id
unii		63937KV33D	openfda.unii

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

ADVERSE REACTIONS: The most frequently reported adverse reactions are minor ocular irritations, redness, and hypersensitivity reactions. To report SUSPECTED ADVERSE REACTIONS, contact Perrigo at 1-866-634-9120 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch .

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.